Apart from that, clinical evidence also demonstrated that the methylation frequency of MEG3 in NSCLC tissues (ie, 96%) exceeded that in normal tissues (ie, 68%), and MEG3 expression was lower in NSCLC tissues than in normal tissues.47 The gene discussed is MEG3; the disease is non-small cell lung carcinoma.